Skip to content

Effect of Citicoline in Bipolar Disorder in current manic epiode

Additive effect of Citicoline on conventional treatment of Bipolar in curent manic episode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090304001743N17
Enrollment
35
Registered
2020-08-02
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder manic episode. Bipolar Disorder, current episode manic severe with psychotic features

Interventions

Intervention 1: Intervention group: 35 patients diagnosed with Bipolar Disorder in manic phase will be treated with 250 mg /day of Citicolin wich will be one dose through inter muscular injection . Th

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Young Mania Rating Scale greater than or equal to 20 Consent agreement to participate in the study Hospital Admission due to psychiatrist opinion Age greater than or equal to 16

Exclusion criteria

Exclusion criteria: Psychiatric disorders except Bipolar 1 Disorder Not to have medical disease Citicolin Contraindication

Design outcomes

Primary

MeasureTime frame
The effectiveness of Citicoline on reduction of mania episode in bipolar patients administered by YMRS. Timepoint: Assessment of mania status administered by Young Mania Rating Scale at the first date of hospitalization, and the first and second week of receiving Citicoline. Method of measurement: Young Mania Rating Scale.

Secondary

MeasureTime frame
The reduction of mania symptoms. Timepoint: At the start of the study and the first and second week after receiving citicolin. Method of measurement: Young Mania Rating Scale (YMRS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Rezaee

Hamedan University of Medical Sciences

haghighi@umsha.ac.ir+98 81 3827 1066

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026